SEARCH

SEARCH BY CITATION

References

  • 1
    Cancer Statistics in Japan, 2008. Available from URL: http://www.fpcr.or.jp/publication/pdf/statistics2008.pdf
  • 2
    Nakachi K, Imai K, Hoshiyama Y, Sasaba T. The joint effects of two factors in the aetiology of oesophageal cancer in Japan. J Epidemiol Community Health 1988; 42: 35564.
  • 3
    Franceschi S, Talamini R, Barra S et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990; 50: 65027.
  • 4
    Ishiguro S, Sasazuki S, Inoue M et al. Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). Cancer Lett 2009; 275: 2406.
  • 5
    Hanaoka T, Tsugane S, Ando N et al. Alcohol consumption and risk of esophageal cancer in Japan: a case-control study in seven hospitals. Jpn J Clin Oncol 1994; 24: 2416.
  • 6
    Lagergren J, Bergström R, Lindgren A, Nyrén O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 2000; 85: 3406.
  • 7
    Sundelöf M, Lagergren J, Ye W. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer 2008; 44: 156671.
  • 8
    Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer 2002; 99: 8608.
  • 9
    Shibata A, Matsuda T, Ajiki W, Sobue T. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993–2001. Jpn J Clin Oncol 2008; 38: 4648.
  • 10
    Tajima K, Hirose K, Inoue M, Takezaki T, Hamajima N, Kuroishi T. A model of practical cancer prevention for out-patients visiting a hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Asian Pac J Cancer Prev 2000; 1: 3547.
  • 11
    Hamajima N, Matsuo K, Saito T et al. Gene–environment interactions and polymorphism studies of cancer risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACCII). Asian Pac J Cancer Prev 2001; 2: 99107.
  • 12
    Muro K, Ohtsu A, Ishikura S et al. A phase II study of chemoradiotherapy in patients with stage II, III esophageal squamous cell carcinoma (ESCC): (JCOG 9906). Proc Am Soc Clin Oncol 2007; 25: 18s. (abstr 15137)
  • 13
    Muro K, Ando N, Nishimaki T. A phase II study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus: the Japan Clinical Oncology Group (JCOG) trial (JCOG 9905). Proc Am Soc Clin Oncol 2003; 22: 277 (abstr 1112).
  • 14
    Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group Trial (JCOG 9516). Jpn J Clin Oncol 2004; 34: 6159.
  • 15
    Oze I, Matsuo K, Suzuki T et al. Impact of multiple alcohol dehydrogenase gene polymorphisms on risk of upper aerodigestive tract cancers in a Japanese population. Cancer Epidemiol Biomarkers Prev 2004; 18: 3097102.
  • 16
    Matsuo K, Hamajima N, Shinoda M et al. Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis 2001; 22: 9136.
  • 17
    Browman GP, Wong G, Hodson I et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993; 328: 15963.
  • 18
    Nozoe T, Korenaga D, Kabashima A, Sugimachi K. Smoking-related increase of O(6)-methylguanine-DNA methyltransferase expression in squamous cell carcinoma of the esophagus. Cancer Lett 2002; 184: 4955.
  • 19
    Ohba T, Kometani T, Shoji F et al. Expression of an X-family DNA polymerase, pol lambda, in the respiratory epithelium of non-small cell lung cancer patients with habitual smoking. Mutat Res 2009; 677: 6671.
  • 20
    Hwang IG, Ahn MJ, Park BB et al. ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy. Cancer 2008; 113: 137986.